Paul Kelly - Jun 26, 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Operating Officer, Director
Signature
/s/ Paul Kelly
Stock symbol
RLMD
Transactions as of
Jun 26, 2025
Transactions value $
$0
Form type
4
Date filed
6/30/2025, 07:27 PM
Previous filing
May 20, 2025
Next filing
Nov 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelly Paul Edward Chief Operating Officer, Director C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES, /s/ Paul Kelly 2025-06-30 0001658544

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +400K $0.00 400K Jun 26, 2025 Common Stock 400K $0.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 16 equal quarterly installments commencing on September 26, 2025.